GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 02:40PM BST. Market open.
| Previous close | 1,651.00 |
| Open | 1,656.50 |
| Bid | 1,647.00 x 0 |
| Ask | 1,648.00 x 0 |
| Day's range | 1,647.00 - 1,661.50 |
| 52-week range | 1,302.60 - 1,725.81 |
| Volume | |
| Avg. volume | 8,877,445 |
| Market cap | 67.297B |
| Beta (5Y monthly) | 0.27 |
| PE ratio (TTM) | 13.72 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.64 (3.88%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | N/A |
- CityAM
US regulator accepts GSK’s application to expand treatment of cancer drug
The treatment, Jemperli, will now be classed as being able to help all adult patients with primary advanced or recurrent endometrial cancer. It is used alongside chemotherapy.
- Fool.co.uk
Is this FTSE growth superstar set to soar even higher on new drug results?
New drugs should significantly boost this FTSE stock’s earnings in my view. But even without them it looked very undervalued to me. The post Is this FTSE growth superstar set to soar even higher on new drug results? appeared first on The Motley Fool UK.
- Fool.co.uk
Forget investing for the next five years, 5 stocks that can last forever
Two US-listed stocks, and three right here in Blighty -- find out the names of five businesses that have our authors' backing today! The post Forget investing for the next five years, 5 stocks that can last forever appeared first on The Motley Fool UK.
© 2024 Yahoo. All rights reserved.